Clinical Trial

ROME GS System Study

Name: ROME GS System Study — clinical trial record (NCT07518004)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this clinical investigation is to demonstrate that the proposed physical changes to the ROME GS Sensor do not have any adverse impact on safety and performance when compared to the Eversense 365 Sensor.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-04-01.

Trial Details

NCT Number	NCT07518004
Lead Sponsor	Senseonics, Inc.
Conditions	Diabetes, Diabetes Melletus, Type 1, Diabetes Mellitus, Type 2
Enrollment	60 participants
Start Date	2026-02-12
Primary Completion	2028-08 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-21